Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
888 | nsp12:I888-; | CL-3b; |
103 | nsp12:K103N; | CL-3d;CL-3e;CL-3f; |
121 | nsp12:K121E; | CL-3f; |
121 | nsp12:K121R; | CL-3f; |
143 | nsp12:K143E; | CL-3d; |
143 | nsp12:K143Q; | CL-3e; |
159 | nsp12:K159I; | CL-3f; |
159 | nsp12:K159N; | CL-3e; |
159 | nsp12:K159R; | CL-3c;CL-3f; |
160 | nsp12:K160-; | CL-3e; |
263 | nsp12:K263N; | CL-2;CL-3b;CL-3d;CL-3e;CL-3f; |
267 | nsp12:K267N; | CL-3b;CL-3c;CL-3d;CL-3e;CL-3f; |
272 | nsp12:K272-; | CL-3d; |
272 | nsp12:K272R; | CL-2; |
288 | nsp12:K288-; | CL-3b;CL-3f; |
332 | nsp12:K332-; | CL-3c; |
332 | nsp12:K332Q; | CL-3b; |
369 | nsp12:K369N; | CL-3e; |
411 | nsp12:K411-; | CL-3c; |
411 | nsp12:K411Q; | CL-3e; |
41 | nsp12:K41R; | CL-3b; |
426 | nsp12:K426-; | CL-3e; |
426 | nsp12:K426N; | CL-3b;CL-5; |
47 | nsp12:K47-; | CL-3e; |
478 | nsp12:K478-; | CL-3b;CL-3c;CL-3d; |
478 | nsp12:K478R; | CL-1a_3e; |
59 | nsp12:K59-; | CL-3b;CL-3f; |
603 | nsp12:K603N; | CL-3e; |
603 | nsp12:K603R; | CL-3e; |
641 | nsp12:K641R; | CL-1a_3c;CL-3c; |
714 | nsp12:K714E; | CL-3e; |
718 | nsp12:K718-; | CL-3e; |
718 | nsp12:K718R; | CL-1a_3c;CL-3c; |
751 | nsp12:K751R; | CL-3f; |
780 | nsp12:K780-; | CL-3b;CL-3c;CL-3f; |
780 | nsp12:K780E; | CL-3d;CL-3f; |
780 | nsp12:K780N; | CL-3b; |
780 | nsp12:K780T; | CL-1b;CL-3d; |
807 | nsp12:K807-; | CL-3f; |
890 | nsp12:K890R; | CL-3b; |
91 | nsp12:K91-; | CL-3b;CL-3c;CL-3d;CL-3f; |
146 | nsp12:L146-; | CL-1b; |
172 | nsp12:L172V; | CL-2; |
186 | nsp12:L186S; | CL-3e; |
186 | nsp12:L186V; | CL-1a_3d;CL-3d; |
19 | nsp12:L19F; | CL-2; |
205 | nsp12:L205-; | CL-3e; |
205 | nsp12:L205P; | CL-3c; |
207 | nsp12:L207V; | CL-3b; |
212 | nsp12:L212-; | CL-3e;CL-5; |
Page 163 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com